Johnson & Johnson Reportedly Settles California Talc Case Midtrial

Johnson & Johnson JNJ has settled its California talc case midtrial and is likely to avoid a huge judgement, according to Law 360.

Alameda County Superior Court Judge Stephen Kaus in Oakland, California reportedly made the announcement to the jury today.

Johnson & Johnson has faced more than 14,000 claims that its talc powder caused ovarian cancer and mesothelioma, a rare cancer linked to asbestos exposure.

In December, a jury in Los Angeles sided with the company in the case of Amy Fong, who alleged Johnson & Johnson’s talc contained asbestos and caused her to develop mesothelioma, reports the Fierce Pharma.

Johnson & Johnson shares were down 0.49% at $143.59 at the time of publication. The stock has a 52-week high of $148.99 and a 52-week low of $121.

Related Links:

Johnson & Johnson Voluntarily Recalls A Batch Of Baby Powder

Johnson & Johnson Trades Higher On Q3 Beat-And-Raise, Despite Legal Entanglements

Public domain photo via Wikimedia

JNJ Logo
JNJJohnson & Johnson
$154.91-0.30%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum
68.85
Growth
50.72
Quality
5.41
Value
21.46
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs

Posted In:
Comments
Loading...